Eye movement desensitization and reprocessing (EMDR): efficacy in improving clinical, neuropsychological, and quality of life in women victims of violence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85117262

Enrollment

170

Registered

2023-11-15

Start date

2019-05-05

Completion date

Unknown

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women exposed to gender-based violence who show symptoms of anxiety, depression and post-traumatic stress, in addition to low performance in cognitive functioning, or that limits performance in daily life Mental and Behavioural Disorders

Interventions

A total of 120 women exposed to gender-based violence participated

the women were identified and invited to participate in the study through professionals from the public health network of the Tabacundo Health Center in Ecuador. The participants were randomly divided

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Exposed to gender violence (physical, psychological and/or sexual) 2. Between 18 and 50 years of age 3. Signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Intelligence quotient (IQ) lower than 70 2. History of brain damage 3. History of severe neurological or psychiatric illness 4. History of toxic consumption 5. Presence of sensory alterations that impeded the performance of the tests

Design outcomes

Primary

Measure	Time frame
Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment: Neuropsychological functioning was measured using the following tests: 1. The Rey Auditory Verbal Learning Test RAV LT. 2. Coding - subtest WAIS IV. 3. Test D2. measures selective and sustained attention. 4. Trail Making Test, part A (TMT-A) and part B (TMT-B). 5. Stroop Test. An instrument that assesses complex attention. 6. Phonological Verbal Fluency Test PVFT. 7. Semantic Verbal Fluency Test SVFT. Assesses the ability to retrieve stored semantic information.	—

Measure

Time frame

Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment: Neuropsychological functioning was measured using the following tests: 1. The Rey Auditory Verbal Learning Test RAV LT. 2. Coding - subtest WAIS IV. 3. Test D2. measures selective and sustained attention. 4. Trail Making Test, part A (TMT-A) and part B (TMT-B). 5. Stroop Test. An instrument that assesses complex attention. 6. Phonological Verbal Fluency Test PVFT. 7. Semantic Verbal Fluency Test SVFT. Assesses the ability to retrieve stored semantic information.

—

Secondary

Measure	Time frame
Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment: 1. Gender violence - Questionnaire on violence 2. Anxiety and depression are measured using the Hospital Anxiety and Depression Scale HADS scale 3. Posttraumatic Stress Disorder is measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) 4. Quality of Life is measured using GENCAT Scale	—

Measure

Time frame

Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment: 1. Gender violence - Questionnaire on violence 2. Anxiety and depression are measured using the Hospital Anxiety and Depression Scale HADS scale 3. Posttraumatic Stress Disorder is measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) 4. Quality of Life is measured using GENCAT Scale

—

Countries

Ecuador

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026